XML 104 R72.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings per Share (Details) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Numerator:    
Net income attributable to Biogen Inc. $ 303.8 $ 410.2
Weighted-average shares used in calculating:    
Weighted average number of common shares outstanding 147,100 151,900
Effect of dilutive securities:    
Dilutive potential common shares 500 400
Shares used in calculating diluted earnings per share 147,600 152,300
Time-vested restricted stock units    
Effect of dilutive securities:    
Stock units 300 200
Market stock units    
Effect of dilutive securities:    
Stock units 100 100
Performance stock units settled in stock    
Effect of dilutive securities:    
Stock units 100 100